Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site




VERTEX PHARMACEUTICALS INCORPORATED (VRTX)

The QuantWave forecast for VRTX vertex pharmaceuticals incorporated

Vertex Pharmaceuticals Incorporated is a biotechnology company that specializes in the discovery, development, and commercialization of innovative medicines for the treatment of serious diseases. With its headquarters in Boston, Massachusetts, the company has established itself as a leader in the field of precision medicine, utilizing advanced scientific techniques to target specific genetic mutations underlying various disorders. Vertex is known for its groundbreaking therapies for cystic fibrosis, a life-threatening genetic disease affecting the lungs and digestive system. The company's research and development efforts also extend to other progressive diseases, such as alpha-1 antitrypsin deficiency and sickle cell disease. With a strong focus on collaboration and strategic partnerships, Vertex continually pushes the boundaries of scientific knowledge to deliver life-changing treatments to patients in need.
The graph shows the results of our forecasting system for VRTX. You can view historical price data with some markers indicating where our system has been signaling and where the projected targets have been achieved. This demonstrates to what extent our system's forecasts have been justified in real market conditions.

We do not display all the achieved goals on the graph, you can get detailed information about the achieved goals in the corresponding section on this page

The graph is interactive. When you hover over the icons of the achieved goals, you can see where the forecast was created.

Access the VRTX Forecast by QuantWave

Stock ticker: VRTX
Name: VERTEX PHARMACEUTICALS INCORPORATED
Sector: Healthcare
Investing Risk: HIGH
Forecast length: 3 days
Accuracy: 41.81 %
Average profit per target: 4.96 %


VRTX Achieves Targets with Precision, as Predicted by QuantWave

Show news about the achieved forecast
Signal Date Signal Price Date Reached Price Reached Profit Direction
2022-06-07271.86 $2022-08-09298.83 $ 9.92%
2024-02-27430.92 $2024-07-10491.62 $ 14.09%
2024-03-05415.44 $2024-06-04474.95 $ 14.32%
2024-03-12412.45 $2024-07-10491.62 $ 19.2%
2024-05-07410.24 $2025-08-05374.98 $ 8.59%
2024-05-14428.59 $2024-07-30502.6 $ 17.27%
2024-10-01469.76 $2024-12-19396.64 $ 15.57%
2024-10-08458.94 $2024-12-19396.64 $ 13.57%
2024-10-15484.3 $2024-12-19396.64 $ 18.1%
2024-10-22474.91 $2024-12-19396.64 $ 16.48%
2024-12-13463.73 $2025-03-17513.76 $ 10.79%
2024-12-17469.24 $2025-03-17513.76 $ 9.49%
2024-12-24408.18 $2025-08-08366.54 $ 10.2%
2024-12-31402.7 $2025-08-08366.54 $ 8.98%
2024-12-31402.7 $2025-08-08366.54 $ 8.98%
2025-01-07408.32 $2025-08-08366.54 $ 10.23%
2025-01-14411.66 $2025-08-05374.98 $ 8.91%
2025-01-28440.68 $2025-08-05374.98 $ 14.91%
2025-05-28445.1 $2025-08-05374.98 $ 15.75%
2025-05-29447.09 $2025-08-05374.98 $ 16.13%
2025-05-30442.05 $2025-08-05374.98 $ 15.17%
2025-05-30442.05 $2025-08-05374.98 $ 15.17%
2025-05-30442.05 $2025-08-05374.98 $ 15.17%
2025-06-02445.43 $2025-08-05374.98 $ 15.82%
2025-06-03446.48 $2025-08-05374.98 $ 16.01%
2025-06-04445.85 $2025-08-05374.98 $ 15.9%
2025-06-05443.82 $2025-08-05374.98 $ 15.51%
2025-06-17441.99 $2025-07-09478.97 $ 8.37%
2025-06-20440.87 $2025-07-09478.97 $ 8.64%
2025-06-27441.3 $2025-07-09478.97 $ 8.54%
2025-06-27441.3 $2025-07-09478.97 $ 8.54%
2025-06-27441.3 $2025-07-09478.97 $ 8.54%

Access the VRTX Forecast by QuantWave


The latest news about the achievement of forecasting results and global news about vertex pharmaceuticals incorporated


VRTXAugust 15, 2025Vertex Pharmaceuticals Incorporated VRTX - Leading the Way in Rare Disease Treatments  ~1 min.

Vertex Pharmaceuticals Incorporated (VRTX) continues to make headlines as a leader in developing treatments for rare diseases....


VRTXAugust 5, 2025VERTEX PHARMACEUTICALS INCORPORATED Stock Hits Forecast Price Target, Generating 8.59% Profit  ~1 min.

On May 7, 2024, QuantWave issued a short signal for VERTEX PHARMACEUTICALS INCORPORATED with a price target of 374.98 $....


VRTXAugust 5, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits Price Target with 15.82% Profit, Validates QuantWave's Forecasting Accuracy  ~2 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) recently achieved the price target forecast set by QuantWave, a notable milestone that not only indicates the platform's forecasting accuracy but also presents a lucrative opportunity for investors. The forecast signal was generated on June 2, 2025, when the stock was trading at $445.43, with a predicted short direction. Fast forward to August 5, 2025, th...


VRTXAugust 5, 2025VERTEX PHARMACEUTICALS INCORPORATED Successfully Hits Price Target Forecast with 16.01% Profit: A Triumph for QuantWave's Analytics  ~2 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) recently achieved the forecasted price target, as predicted by QuantWave's automated forecasting platform on 2025-06-03....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits Price Target with 8.54% Profit Margin  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) recently achieved its price target forecast, generating an 8.54% profit margin for investors....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Stock Hits Forecast Target with 7.36% Profit  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) stock successfully achieved the price target forecast set by QuantWave, a leading automated forecasting platform, with a profitable outcome of 7.36%....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Stock Reaches Price Target Forecast with 8.02% Profit  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED stock successfully reached the price target forecast set by QuantWave on July 9, 2025....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits Forecast Target with 8.37% Profit: A Success Story for QuantWave  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) recently achieved the forecast price target set by QuantWave, resulting in a profit of 8.37% for investors who followed the long prediction signal....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Stock Hits Forecasted Price Target with 8.64% Profit  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) stock successfully reached the forecasted price target set by QuantWave on 2025-06-20, with a predicted long direction. The stock was valued at 440....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits QuantWave Forecast Target with 7.59% Profit  ~2 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) has successfully reached the forecast price target set by QuantWave on June 30, 2025....





Other QuantWave offers: